Doximity Revenue 2020-2025 | DOCS
Doximity annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Doximity revenue for the quarter ending March 31, 2025 was $0.138B, a 17.14% increase year-over-year.
- Doximity revenue for the twelve months ending March 31, 2025 was $0.570B, a 19.98% increase year-over-year.
- Doximity annual revenue for 2025 was $0.57B, a 19.98% increase from 2024.
- Doximity annual revenue for 2024 was $0.475B, a 13.45% increase from 2023.
- Doximity annual revenue for 2023 was $0.419B, a 21.98% increase from 2022.
| Doximity Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $570 |
| 2024 | $475 |
| 2023 | $419 |
| 2022 | $344 |
| 2021 | $207 |
| 2020 | $116 |
| 2019 | $86 |
| Doximity Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $138 |
| 2024-12-31 | $169 |
| 2024-09-30 | $137 |
| 2024-06-30 | $127 |
| 2024-03-31 | $118 |
| 2023-12-31 | $135 |
| 2023-09-30 | $114 |
| 2023-06-30 | $108 |
| 2023-03-31 | $111 |
| 2022-12-31 | $115 |
| 2022-09-30 | $102 |
| 2022-06-30 | $91 |
| 2022-03-31 | $94 |
| 2021-12-31 | $98 |
| 2021-09-30 | $79 |
| 2021-06-30 | $73 |
| 2021-03-31 | $67 |
| 2020-12-31 | $59 |
| 2020-09-30 | $45 |
| 2020-06-30 | $36 |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.561B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |